Girl in a jacket

InnoCore specializes in formulation, process development and manufacturing of long acting and minimally invasive injectable drug delivery products. We are a target-driven and cost-efficient organization committed to delivering products and services that offer added value to our partners and improve the quality of life of patients. Flexibility, compliance with the highest international quality standards and a true belief in the value of collaborative partnerships are the key elements of the InnoCore approach. InnoCore is a privately owned company and is based in The Netherlands.

 

Mission

 

Science delivering tomorrow's medicine

 

 

 

InnoCore is dedicated to develop minimally invasive and long-acting injectable polymer based depot formulation products for precise delivery of small molecules, peptides and protein therapeutics as to contribute to enhanced patient care.

 

History

  • Robert Hof (CEO) joined InnoCore

  • Succesfully developed semi-automated method for high throughput in-vitro release testing 

  • More than 20 product development projects ongoing 

  • Awarded by the Bill and Melissa Gates Foundation to develop a long-acting injectable contraceptive implant

  • Gates Foundation supported consortium on microneedle contraceptive

  • InnoCore renewed the GMP certificate and converted the laboratory authorization to a manufacturer’s authorization for physical/chemical testing of investigational medicines

  • InnoCore is offering InGell Technologies as a service

  • Winnter Enterpreneurs Award Groningen

  • InnoCore signs an Exclusive License with Allergan on Ophthalmology.

     

  • CE Mark for SynBiosys containing product with Orbus Neich. 

  • InnoCore established a License in the field of device coatings with its US partner Surmodics Inc.

  • Foundation of InnoCore

This website uses (anonymized) analytical and functional cookies

Privacy Statement